(MENAFN- Trend News Agency ) Medical journal Lancet's latest report on COVID-19 situation in India that discusses the Indian government's management of the pandemic is yet another attempt by the big pharma lobby to undermine the "abilities of a developing country to challenge their monopoly by rolling out vaccines at throwaway prices," according to a report in EUreporter.
At a time when aid, empathy and partnerships happen to be India's foremost concerns, the EUreporter said that globally reputed publications should desist from "toying with politicized articles and commercial ideas, which are deeply demoralizing to any nation in such testing times"
The Brussels-based news website said repeated reports and articles in the international media have questioned the vaccination drive and the ability of India to mass-produce vaccines to cater for the world in order to downplay Indian vaccines and subsequently fill the momentary vacuum in the market.
"This article appears to be an attempt on the similar lines where the author has used statistics of convenience to push the agenda in the favour of foreign vaccines using reputed platforms, shrouding the big Pharma's agendas in an academic language in its search for legitimizing its agendas," EUreporter noted.
Medical journal Lancet launched a scathing attack against the Indian government and defined the second Covid wave in India as a "self-inflicted national catastrophe".
"Hospitals are overwhelmed, and health workers are exhausted and becoming infected. Social media is full of desperate people (doctors and the public) seeking medical oxygen, hospital beds, and other necessities," the Lancet wrote.
MENAFN14052021000187011040ID1102080178
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.